Neurocrine Biosciences (NBIX) had the highest return between September 1, 2014 and January 31, 2015 by a large-cap US stock, returning 103.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Neurocrine Biosciences (NBIX) | 9/1/2014 - 1/31/2015 | 103.51% |
Genmab A-S (GMAB) | 9/1/2014 - 1/31/2015 | 68.45% |
Axon Enterprise (AXON) | 9/1/2014 - 1/31/2015 | 67.76% |
Lululemon Athletica (LULU) | 9/1/2014 - 1/31/2015 | 65.31% |
Manhattan Associates (MANH) | 9/1/2014 - 1/31/2015 | 54.57% |
Palo Alto Networks (PANW) | 9/1/2014 - 1/31/2015 | 48% |
Super Micro Computer (SMCI) | 9/1/2014 - 1/31/2015 | 46.87% |
Incyte (INCY) | 9/1/2014 - 1/31/2015 | 46.26% |
Skyworks Solutions (SWKS) | 9/1/2014 - 1/31/2015 | 45.61% |
Electronic Arts (EA) | 9/1/2014 - 1/31/2015 | 45.06% |
United Airlines (UAL) | 9/1/2014 - 1/31/2015 | 44.52% |
Paycom Soft (PAYC) | 9/1/2014 - 1/31/2015 | 44.27% |
Southwest Airlines (LUV) | 9/1/2014 - 1/31/2015 | 41.04% |
Centene (CNC) | 9/1/2014 - 1/31/2015 | 39.82% |
Burlington Stores (BURL) | 9/1/2014 - 1/31/2015 | 38.7% |
Intracellular Th (ITCI) | 9/1/2014 - 1/31/2015 | 36.86% |
Biomarin Pharmaceutical (BMRN) | 9/1/2014 - 1/31/2015 | 35.98% |
Kroger (KR) | 9/1/2014 - 1/31/2015 | 35.74% |
CyberArk Software (CYBR) | 9/1/2014 - 1/31/2015 | 35.48% |
Ulta Beauty (ULTA) | 9/1/2014 - 1/31/2015 | 35.38% |
Alnylam Pharmaceuticals (ALNY) | 9/1/2014 - 1/31/2015 | 34.48% |
DexCom (DXCM) | 9/1/2014 - 1/31/2015 | 34.25% |
Stellantis (STLA) | 9/1/2014 - 1/31/2015 | 34.11% |
Darden Restaurants (DRI) | 9/1/2014 - 1/31/2015 | 32.43% |
Dollar Tree (DLTR) | 9/1/2014 - 1/31/2015 | 31.98% |
Large-cap stocks are treated as having a market cap of $10B+.
